Related Experiment Video
Updated: May 30, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control
María Rodríguez-Muñoz1, Pilar Sánchez-Blázquez, Ana Vicente-Sánchez
1CIBER of Mental Health (CIBERSAM), ISCIII, Madrid, Spain.
Abstract:
The capacity of opioids to alleviate inflammatory pain is negatively regulated by the glutamate-binding N-methyl-D-aspartate receptor (NMDAR). Increased activity of this receptor complicates the clinical use of opioids to treat persistent neuropathic pain. Immunohistochemical and ultrastructural studies have demonstrated the coexistence of both receptors within single neurons of the CNS, including those in the mesencephalic periaqueductal gray (PAG), a region that is implicated in the opioid control of nociception. We now report that mu-opioid receptors (MOR) and NMDAR NR1 subunits associate in the postsynaptic structures of PAG neurons. Morphine disrupts this complex by protein kinase-C (PKC)-mediated phosphorylation of the NR1 C1 segment and potentiates the NMDAR-CaMKII, pathway that is implicated in morphine tolerance. Inhibition of PKC, but not PKA or GRK2, restored the MOR-NR1 association and rescued the analgesic effect of morphine as well. The administration of N-methyl-D-aspartic acid separated the MOR-NR1 complex, increased MOR Ser phosphorylation, reduced the association of the MOR with G-proteins, and diminished the antinociceptive capacity of morphine. Inhibition of PKA, but not PKC, CaMKII, or GRK2, blocked these effects and preserved morphine antinociception. Thus, the opposing activities of the MOR and NMDAR in pain control affect their relation within neurons of structures such as the PAG. This finding could be exploited in developing bifunctional drugs that would act exclusively on those NMDARs associated with MORs.
Insights
Opioid pain relief is hindered by N-methyl-D-aspartate receptors (NMDARs). We found mu-opioid receptors (MOR) and NMDARs interact in pain-controlling brain regions, offering new therapeutic targets.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Opioid analgesia is limited by N-methyl-D-aspartate receptors (NMDARs), particularly in neuropathic pain.
- Mu-opioid receptors (MOR) and NMDARs coexist in neurons of the periaqueductal gray (PAG), a key area for opioid pain control.
Purpose of the Study:
- To investigate the physical association between MOR and NMDAR in PAG neurons.
- To elucidate the molecular mechanisms underlying the interaction and its impact on opioid efficacy and tolerance.
Main Methods:
- Immunohistochemical and ultrastructural studies to confirm receptor co-localization.
- Biochemical assays to analyze MOR-NMDAR complex formation and disruption.
- Pharmacological manipulations involving kinase inhibitors (PKC, PKA, GRK2) and NMDAR agonists.
Main Results:
- MOR and NMDAR NR1 subunits form a complex in postsynaptic PAG neurons.
- Morphine disrupts this complex via PKC-mediated NR1 phosphorylation, potentiating NMDAR activity and contributing to tolerance.
- NMDAR activation dissociates the complex, reduces MOR-G-protein coupling, and diminishes morphine's antinociceptive effects, an effect blocked by PKA inhibition.
Conclusions:
- The interaction between MOR and NMDAR in the PAG is dynamically regulated and influences opioid analgesia and tolerance.
- PKC and PKA play opposing roles in modulating the MOR-NMDAR complex and opioid response.
- Targeting MOR-associated NMDARs presents a potential strategy for developing novel analgesics with improved efficacy.
Related Concept Videos
Opioid Receptors: Overview
Analgesia and Pain Management
Pain
Nociception
Opioid Analgesics: Morphine and Other Natural Cogeners
Ligand-Gated Ion Channel Receptor: Gating Mechanism
